Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 346

1.

IgM, IgG, and IgA Influenza-Specific Plasma Cells Express Divergent Transcriptomes.

Price MJ, Hicks SL, Bradley JE, Randall TD, Boss JM, Scharer CD.

J Immunol. 2019 Sep 9. pii: ji1900285. doi: 10.4049/jimmunol.1900285. [Epub ahead of print]

PMID:
31501259
2.

Oxygenation reactions catalyzed by the F557V mutant of soybean lipoxygenase-1: Evidence for two orientations of substrate binding.

Hershelman D, Kahler KM, Price MJ, Lu I, Fu Y, Plumeri PA, Karaisz F, Bassett NF, Findeis PM, Clapp CH.

Arch Biochem Biophys. 2019 Aug 29;674:108082. doi: 10.1016/j.abb.2019.108082. [Epub ahead of print]

PMID:
31473191
3.

Evaporative heat loss insufficient to attain heat balance at rest in individuals with a spinal cord injury at high ambient temperature.

Griggs KE, Havenith G, Price MJ, Goosey-Tolfrey VL.

J Appl Physiol (1985). 2019 Aug 15. doi: 10.1152/japplphysiol.00893.2018. [Epub ahead of print]

PMID:
31414956
4.

Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention.

Olivier CB, Bhatt DL, Leonardi S, Stone GW, Gibson CM, Steg PG, Hamm CW, Wilson MD, Mangum S, Price MJ, Prats J, White HD, Lopes RD, Harrington RA, Mahaffey KW; CHAMPION PHOENIX Investigators * .

Circ Cardiovasc Interv. 2019 Jul;12(7):e007342. doi: 10.1161/CIRCINTERVENTIONS.118.007342. Epub 2019 Jul 12.

PMID:
31296081
5.

The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIX.

Yong CM, Sundaram V, Abnousi F, Olivier CB, Yang J, Stone GW, Steg PG, Michael Gibson C, Hamm CW, Price MJ, Deliargyris EN, Prats J, White HD, Harrington RA, Bhatt DL, Mahaffey KW; CHAMPION PHOENIX Investigators.

Clin Cardiol. 2019 Jun 29. doi: 10.1002/clc.23221. [Epub ahead of print]

6.

Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy.

Kedhi E, Latib A, Abizaid A, Kandzari D, Kirtane AJ, Mehran R, Price MJ, Simon D, Worthley S, Zaman A, Brar S, Liu M, Stone GW, Windecker S.

Am Heart J. 2019 Aug;214:134-141. doi: 10.1016/j.ahj.2019.04.017. Epub 2019 May 6.

7.

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.

Sibbing D, Aradi D, Alexopoulos D, Ten Berg J, Bhatt DL, Bonello L, Collet JP, Cuisset T, Franchi F, Gross L, Gurbel P, Jeong YH, Mehran R, Moliterno DJ, Neumann FJ, Pereira NL, Price MJ, Sabatine MS, So DYF, Stone GW, Storey RF, Tantry U, Trenk D, Valgimigli M, Waksman R, Angiolillo DJ.

JACC Cardiovasc Interv. 2019 Aug 26;12(16):1521-1537. doi: 10.1016/j.jcin.2019.03.034. Epub 2019 Jun 12. Review.

PMID:
31202949
8.

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.

Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, Cuisset T, Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, Kim HS, Kimura T, Konishi A, Laschinger J, Leon MB, Magee PFA, Mitsutake Y, Mylotte D, Pocock S, Price MJ, Rao SV, Spitzer E, Stockbridge N, Valgimigli M, Varenne O, Windhoevel U, Yeh RW, Krucoff MW, Morice MC.

Eur Heart J. 2019 Aug 14;40(31):2632-2653. doi: 10.1093/eurheartj/ehz372.

9.

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.

Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, Cuisset T, Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, Kim HS, Kimura T, Konishi A, Laschinger J, Leon MB, Magee PFA, Mitsutake Y, Mylotte D, Pocock S, Price MJ, Rao SV, Spitzer E, Stockbridge N, Valgimigli M, Varenne O, Windhoevel U, Yeh RW, Krucoff MW, Morice MC.

Circulation. 2019 Jul 16;140(3):240-261. doi: 10.1161/CIRCULATIONAHA.119.040167. Epub 2019 May 22.

10.

Device-Related Thrombus After Transcatheter Left Atrial Appendage Closure.

Price MJ.

JACC Cardiovasc Interv. 2019 Jun 10;12(11):1015-1017. doi: 10.1016/j.jcin.2019.03.039. Epub 2019 May 15. No abstract available.

PMID:
31103539
11.

Transcatheter Mitral Valve Repair and Replacement: New Standards of Care and New Horizons for Therapy.

Price MJ.

Interv Cardiol Clin. 2019 Jul;8(3):xi-xii. doi: 10.1016/j.iccl.2019.04.001. No abstract available.

PMID:
31078188
12.

Transcatheter Edge-to-Edge Repair for Primary (Degenerative) Mitral Regurgitation: Registries and Trials.

Desai D, Price MJ.

Interv Cardiol Clin. 2019 Jul;8(3):245-259. doi: 10.1016/j.iccl.2019.02.007. Epub 2019 Apr 12. Review.

PMID:
31078180
13.

Empirical comparison of univariate and multivariate meta-analyses in Cochrane Pregnancy and Childbirth reviews with multiple binary outcomes.

Price MJ, Blake HA, Kenyon S, White IR, Jackson D, Kirkham JJ, Neilson JP, Deeks JJ, Riley RD.

Res Synth Methods. 2019 Sep;10(3):440-451. doi: 10.1002/jrsm.1353. Epub 2019 Aug 12.

PMID:
31058440
14.

Periprocedural Outcomes According to Timing of Clopidogrel Loading Dose in Patients Who Did Not Receive P2Y12 Inhibitor Pretreatment.

Abtan J, Ducrocq G, Steg PG, Stone GW, Mahaffey KW, Gibson CM, Hamm CW, Price MJ, Prats J, Deliargyris EN, White HD, Harrington RA, Bhatt DL.

Circ Cardiovasc Interv. 2019 Mar;12(3):e007445. doi: 10.1161/CIRCINTERVENTIONS.118.007445.

PMID:
30871355
15.

Impact of glycaemic control on fracture risk in 5368 people with newly diagnosed Type 1 diabetes: a time-dependent analysis.

Thayakaran R, Perrins M, Gokhale KM, Kumaran S, Narendran P, Price MJ, Nirantharakumar K, Toulis KA.

Diabet Med. 2019 Aug;36(8):1013-1019. doi: 10.1111/dme.13945. Epub 2019 Apr 5.

PMID:
30848519
16.

Prevalence of hyperplasia and cancer in endometrial polyps in women with postmenopausal bleeding: A systematic review and meta-analysis.

Ghoubara A, Price MJ, Fahmy MSE, Ait-Allah AS, Ewies A.

Post Reprod Health. 2019 Jun;25(2):86-94. doi: 10.1177/2053369119833583. Epub 2019 Mar 7. No abstract available.

PMID:
30845879
17.

Percutaneous Coronary Intervention Gathers No Moss.

Price MJ.

Interv Cardiol Clin. 2019 Apr;8(2):ix. doi: 10.1016/j.iccl.2019.01.002. Epub 2019 Jan 22. No abstract available.

PMID:
30832946
18.

Newer-generation Metallic Stents: Design, Performance Characteristics, and Outcomes.

Azarbal F, Price MJ.

Interv Cardiol Clin. 2019 Apr;8(2):95-109. doi: 10.1016/j.iccl.2018.11.001. Review.

PMID:
30832945
19.

When Smoke Does Not Always Mean There Is Fire: Using Isoproterenol for Better Visualization of the Left Atrial Appendage Prior to Transcatheter Closure.

Pandey AC, Smith MR, Olson N, Price MJ, Gibson DN.

JACC Clin Electrophysiol. 2019 Jan;5(1):136-137. doi: 10.1016/j.jacep.2018.09.018. No abstract available.

PMID:
30678781
20.

Prognostic prediction models for diabetic retinopathy progression: a systematic review.

Haider S, Sadiq SN, Moore D, Price MJ, Nirantharakumar K.

Eye (Lond). 2019 May;33(5):702-713. doi: 10.1038/s41433-018-0322-x. Epub 2019 Jan 16. Review.

PMID:
30651592
21.

Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.

Gadiyaram VK, Mohanty S, Gianni C, Trivedi C, Al-Ahmad A, Burkhardt DJ, Gallinghouse JG, Hranitzky PM, Horton RP, Sanchez JE, Della Rocca DG, Di Biase L, Price MJ, Couts L, Gibson D, Natale A.

J Cardiovasc Electrophysiol. 2019 Apr;30(4):511-516. doi: 10.1111/jce.13838. Epub 2019 Jan 15.

PMID:
30623500
22.

Infographic. Thermoregulatory impairment in athletes with a spinal cord injury.

Griggs KE, Havenith G, Price MJ, Goosey-Tolfrey VL.

Br J Sports Med. 2019 Jan 4. pii: bjsports-2018-099853. doi: 10.1136/bjsports-2018-099853. [Epub ahead of print] No abstract available.

PMID:
30610000
23.

Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention.

Angiolillo DJ, Goodman SG, Bhatt DL, Eikelboom JW, Price MJ, Moliterno DJ, Cannon CP, Tanguay JF, Granger CB, Mauri L, Holmes DR, Gibson CM, Faxon DP.

Circulation. 2018 Jul 31;138(5):527-536. doi: 10.1161/CIRCULATIONAHA.118.034722. Review.

PMID:
30571525
24.

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Gallos ID, Papadopoulou A, Man R, Athanasopoulos N, Tobias A, Price MJ, Williams MJ, Diaz V, Pasquale J, Chamillard M, Widmer M, Tunçalp Ö, Hofmeyr GJ, Althabe F, Gülmezoglu AM, Vogel JP, Oladapo OT, Coomarasamy A.

Cochrane Database Syst Rev. 2018 Dec 19;12:CD011689. doi: 10.1002/14651858.CD011689.pub3.

25.

Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial.

Abtan J, Ducrocq G, Steg PG, Stone GW, Mahaffey KW, Gibson CM, Hamm C, Price MJ, Prats J, Elkin S, Deliargyris EN, White HD, Menozzi A, Harrington RA, Bhatt DL; MPH on Behalf of the CHAMPION PHOENIX Investigators.

Int J Cardiol. 2019 Mar 1;278:217-222. doi: 10.1016/j.ijcard.2018.11.114. Epub 2018 Nov 23.

26.

The functional assessment of patients with non-obstructive coronary artery disease: expert review from an international microcirculation working group.

Widmer RJ, Samuels B, Samady H, Price MJ, Jeremias A, Anderson RD, Jaffer FA, Escaned J, Davies J, Prasad M, Grines C, Lerman A.

EuroIntervention. 2019 Mar 20;14(16):1694-1702. doi: 10.4244/EIJ-D-18-00982.

27.

Uterotonic Drugs for the Prevention of Postpartum Haemorrhage: A Cost-Effectiveness Analysis.

Pickering K, Gallos ID, Williams H, Price MJ, Merriel A, Lissauer D, Tobias A, Hofmeyr GJ, Coomarasamy A, Roberts TE.

Pharmacoecon Open. 2019 Jun;3(2):163-176. doi: 10.1007/s41669-018-0108-x.

28.

Thermoregulation following spinal cord injury.

Price MJ, Trbovich M.

Handb Clin Neurol. 2018;157:799-820. doi: 10.1016/B978-0-444-64074-1.00050-1.

PMID:
30459042
29.

Transcatheter Tricuspid and Mitral Valve Edge-to-Edge Repair: The Double Double Orifice.

Bechis MZ, Rubenson DS, Price MJ.

CASE (Phila). 2018 Jun 21;2(5):164-173. doi: 10.1016/j.case.2018.03.003. eCollection 2018 Oct. No abstract available.

30.

Utilization of a Wide Array of Nonvalidated Outcome Scales in Pediatric Orthopaedic Publications: Can't We All Measure the Same Thing?

Truong WH, Price MJ, Agarwal KN, Suryavanshi JR, Somasegar S, Thompson M, Fabricant PD, Dodwell ER.

J Pediatr Orthop. 2019 Feb;39(2):e153-e158. doi: 10.1097/BPO.0000000000001263.

PMID:
30300277
31.

Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention.

Mauri L, Kirtane AJ, Windecker S, Yeh RW, Dauerman HL, Price MJ, Christen T, Allocco DJ, Meredith IT, Kereiakes DJ.

Am Heart J. 2018 Nov;205:110-117. doi: 10.1016/j.ahj.2018.08.004. Epub 2018 Aug 17.

PMID:
30218844
32.

Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial.

Stone GW, Généreux P, Harrington RA, White HD, Gibson CM, Steg PG, Hamm CW, Mahaffey KW, Price MJ, Prats J, Deliargyris EN, Bhatt DL.

Eur Heart J. 2018 Dec 7;39(46):4112-4121. doi: 10.1093/eurheartj/ehy562. Erratum in: Eur Heart J. 2019 Apr 14;40(15):1201.

33.

New Volumetric Analysis Method for Stent Expansion and its Correlation With Final Fractional Flow Reserve and Clinical Outcome: An ILUMIEN I Substudy.

Nakamura D, Wijns W, Price MJ, Jones MR, Barbato E, Akasaka T, Lee SW, Patel SM, Nishino S, Wang W, Gopinath A, Attizzani GF, Holmes D, Bezerra HG.

JACC Cardiovasc Interv. 2018 Aug 13;11(15):1467-1478. doi: 10.1016/j.jcin.2018.06.049.

34.

An Aspartate-Specific Solute-Binding Protein Regulates Protein Kinase G Activity To Control Glutamate Metabolism in Mycobacteria.

Bhattacharyya N, Nkumama IN, Newland-Smith Z, Lin LY, Yin W, Cullen RE, Griffiths JS, Jarvis AR, Price MJ, Chong PY, Wallis R, O'Hare HM.

MBio. 2018 Jul 31;9(4). pii: e00931-18. doi: 10.1128/mBio.00931-18.

35.

Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells.

Owens GL, Price MJ, Cheadle EJ, Hawkins RE, Gilham DE, Edmondson RJ.

Cancer Immunol Immunother. 2018 Oct;67(10):1519-1531. doi: 10.1007/s00262-018-2211-3. Epub 2018 Jul 23.

36.

Imaging in Intervention.

Price MJ, Gonzalez JA.

Interv Cardiol Clin. 2018 Jul;7(3):xi. doi: 10.1016/j.iccl.2018.04.005. Epub 2018 Jun 29. No abstract available.

PMID:
29983153
37.

A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma.

Nieto T, Tomlinson CL, Dretzke J, Bayliss S, Price MJ, Dilworth M, Beggs AD, Tucker O.

BMJ Open. 2018 Jun 30;8(6):e020427. doi: 10.1136/bmjopen-2017-020427.

38.

Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials.

Olivier CB, Sundaram V, Bhatt DL, Leonardi S, Lopes RD, Ding VY, Yang L, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, White HD, Desai M, Lynch DR Jr, Harrington RA, Mahaffey KW; CHAMPION PLATFORM and CHAMPION PCI Investigators.

Int J Cardiol. 2018 Nov 1;270:96-101. doi: 10.1016/j.ijcard.2018.06.034. Epub 2018 Jun 8.

PMID:
29937301
39.

Progressive Upregulation of Oxidative Metabolism Facilitates Plasmablast Differentiation to a T-Independent Antigen.

Price MJ, Patterson DG, Scharer CD, Boss JM.

Cell Rep. 2018 Jun 12;23(11):3152-3159. doi: 10.1016/j.celrep.2018.05.053.

40.

Gestational dyslipidaemia and adverse birthweight outcomes: a systematic review and meta-analysis.

Wang J, Moore D, Subramanian A, Cheng KK, Toulis KA, Qiu X, Saravanan P, Price MJ, Nirantharakumar K.

Obes Rev. 2018 Sep;19(9):1256-1268. doi: 10.1111/obr.12693. Epub 2018 May 21.

PMID:
29786159
41.

Response by Angiolillo et al to Letter Regarding Article, "International Expert Consensus Document on Switching Platelet P2Y12 Receptor Inhibiting Therapies".

Angiolillo DJ, Price MJ, Storey RF.

Circulation. 2018 May 22;137(21):2310-2311. doi: 10.1161/CIRCULATIONAHA.118.033779. No abstract available.

PMID:
29784690
42.

B cell activation and plasma cell differentiation are inhibited by de novo DNA methylation.

Barwick BG, Scharer CD, Martinez RJ, Price MJ, Wein AN, Haines RR, Bally APR, Kohlmeier JE, Boss JM.

Nat Commun. 2018 May 15;9(1):1900. doi: 10.1038/s41467-018-04234-4.

43.

Pharmacogenomic Testing to Select Antiplatelet Therapy.

Price MJ, Angiolillo DJ.

J Am Coll Cardiol. 2018 May 1;71(17):1878-1881. doi: 10.1016/j.jacc.2018.03.021. No abstract available.

PMID:
29699613
44.

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gülmezoglu AM, Hofmeyr GJ, Coomarasamy A.

Cochrane Database Syst Rev. 2018 Apr 25;4:CD011689. doi: 10.1002/14651858.CD011689.pub2. Review. Update in: Cochrane Database Syst Rev. 2018 Dec 19;12:CD011689.

45.

Current State of Left Atrial Appendage Closure.

Kosturakis R, Price MJ.

Curr Cardiol Rep. 2018 Apr 21;20(6):42. doi: 10.1007/s11886-018-0981-z. Review.

PMID:
29680999
46.

Juvenile Osteochondritis Dissecans of the Trochlea: A Cohort Study of 34 Trochlear Lesions Associated With Sporting Activities that Load the Patellofemoral Joint.

Price MJ, Tuca M, Nguyen J, Silberman J, Luderowski E, Uppstrom TJ, Green DW.

J Pediatr Orthop. 2018 Apr 16. doi: 10.1097/BPO.0000000000001174. [Epub ahead of print]

PMID:
29664877
47.

Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition).

Groves EM, Bhatt DL, Steg PG, Deliargyris EN, Stone GW, Gibson CM, Hamm CW, Mahaffey KW, White HD, Angiolillo DJ, Prats J, Harrington RA, Price MJ.

Circ Cardiovasc Interv. 2018 Apr;11(4):e005635. doi: 10.1161/CIRCINTERVENTIONS.117.005635. Erratum in: Circ Cardiovasc Interv. 2018 Sep;11(9):e000036. Angiolillo, Dominick [corrected to Angiolillo, Dominick J].

PMID:
29632238
48.

Percutaneous closure of patent foramen ovale vs. medical treatment for patients with history of cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.

Palaiodimos L, Kokkinidis DG, Faillace RT, Foley TR, Dangas GD, Price MJ, Mastoris I.

Cardiovasc Revasc Med. 2018 Oct - Nov;19(7 Pt B):852-858. doi: 10.1016/j.carrev.2018.02.014. Epub 2018 Mar 2.

PMID:
29576519
49.

The WATCHMAN Left Atrial Appendage Closure Device: Technical Considerations and Procedural Approach.

Price MJ.

Interv Cardiol Clin. 2018 Apr;7(2):201-212. doi: 10.1016/j.iccl.2017.12.010. Review.

PMID:
29526288
50.

Left Atrial Appendage Occlusion: Data Update.

Price MJ.

Interv Cardiol Clin. 2018 Apr;7(2):159-168. doi: 10.1016/j.iccl.2017.12.002. Review.

PMID:
29526285

Supplemental Content

Loading ...
Support Center